Decrease in antioxidant status of plasma and erythrocytes from patients with ankylosing spondylitis
Introduction
Ankylosing spondylitis (AS) is a chronic inflammatory disease of the locomotor system, which may contain periods of aggravation as well as remission, or be chronically progressing, leading to reduction of mobility of the spine and chest. AS most often begins with inflammation of the sacroiliac joints. As the disease progresses, the inflammatory process comprises apophysial joints of the spine, costal cartilages, as well as tissues and ligaments of the spine, leading to their gradual ankylosis. Of the peripheral joints, the most often affected ones include hip, knee, or talar joints. The disease concerns mainly men, its first symptoms occur at the age of 20–30 years [1], [2], [3], [4].
The pathogenesis of AS is yet still unknown. Most authors suggest autoimmune and genetic mechanism, role for several proinflammatory cytokines including interleukines 23 and 17, but also reactive oxygen species (ROS) might be involved in this process [2], [3], [5], [6], [7], [8], [9], [10], [11], [12], [13].
At the present stage of knowledge it is known that ROS take part in the pathogenesis of many pathological processes and diseases. Their participation has been confirmed, among others, in the pathogenesis of inflammatory conditions, ageing process, atherosclerosis, myocardial infarction, Alzheimer's disease, diabetes, neoplastic diseases, as well as various diseases of the locomotor system [14], [15], [16].
Taking into account data presented above the aim of the study was to assess the oxidant/antioxidant status in patients with ankylosing spondylitis in comparison to healthy persons.
Section snippets
Patients
The presented study involved 32 male subjects: 16 patients with ankylosing spondylitis (experimental group, mean age 47 ± 4.7 years) and 16 healthy volunteers (control group, mean age 43 ± 3.9 years). The difference in the age between both groups was not significant (p = 0.802). All patients included to the trial fulfilled the modified New York Criteria for definite diagnosis of AS, which serve as the basis for the ASAS/EULAR recommendations [17].
According to modified New York Criteria (1984) the
Results
The obtained results are shown in Table 1, Table 2, Table 3.
Plasma activity of total SOD and its isoenzyme SOD-ZnCu in patients with AS (13.78 ± 3.64 and 3.62 ± 3.00 NU/mL, respectively) were significantly lower in comparison with the control group (19.87 ± 3.07 and 9.10 ± 2.74 NU/mL, respectively).
In the lysates of erythrocytes of patients with AS a significantly lower activity of SOD (115.9 ± 68.37 vs. 218.9 ± 54.79 NU/mgHb), along with GPx (27.52 ± 14.55 vs. 47.64 ± 9.26 IU/gHb), GST (1.32 ± 1.89 vs. 2.85 ±
Discussion
In numerous reports it has been proven that reactive oxygen species (ROS) play an essential role in the pathogenesis of inflammatory and degenerative diseases of the osteo-muscular system [29], [30], [31], [32], [33], [34], [35].
In the inflammatory disease of the locomotor system, ROS cause, among other things, peroxidation of cell membranes, depolymerization of the hyaluronic acid, degradation of proteoglycanes and collagen, oxidation of proteins, and inhibition of proliferation along with
Conclusion
The results of the study indicate that decrease in the antioxidant status leading to generation of oxidative stress may play an important role in the pathogenesis of ankylosing spondylitis.
Acknowledgments
This work was supported by grant of the State Committee for Scientific Research, Republic of Poland No 3 P05B 156 25.
References (57)
Pathopysiology of ankylosing spondylitis: what's new?
Joint Bone Spine
(2008)- et al.
Free radicals and antioxidants in normal physiological functions and human disease
Int. J. Biochem. Cell Biol.
(2007) Reevaluation of assay methods and establishment of kit for superoxide dismutase activity
Anal. Biochem.
(1984)Catalase in vitro
Methods Enzymol.
(1984)- et al.
Assays for differentiation of glutathione S-transferases
Methods Enzymol.
(1981) - et al.
Assay for peroxides in animal tissue by thiobarbituric acid reaction
Annal. Biochem.
(1979) - et al.
The role of nitric oxide in tissue destruction
Best Pract. Res. Clin. Rheumatol.
(2001) - et al.
Chondrocyte acting as phagocyte to internalize polyethylene wear particles and leads to the elevations of osteoarthritis associated NO and PGE2
Biochem. Biophys. Res. Commun.
(2008) - et al.
The role of reactive oxygen species in homeostasis and degradation of cartilage
Osteoarthritis Cartilage
(2003) - et al.
Cartilage degradation by stimulated human neutrophils: reactive oxygen species decrease markedly the activity of proteolytic enzymes
Chem. Biol.
(2000)
Increased DNA damage and oxidative stress in patients with rheumatoid arthritis
Clin. Biochem.
Lipid peroxidation a common pathogenetic mechanism?
Exp. Toxicol. Pathol.
Biomarkers
Mol. Aspects Med.
Assays for oxidative stress and antioxidant status: applications to research into the biological effectiveness of polyphenols
Am. J. Clin. Nutr.
Total antioxidant capacity
Adv. Clin. Chem.
Ankylosing spondylitis — a systemic disease
Rom. J. Intern. Med.
Rheumatology 2003 — Part I: Research news concerning pathogenesis, epidemiology, diagnosis, and therapy of chronic inflammatory joint diseases
Med. Klin.
Spondyloarthropathies
Am. Fam. Physician
Clinical assessment and outcome research in spondyloarthritis
Curr. Rheumatol. Rep.
Serum oxidative–antioxidative status in patients with ankylosing spondilitis
Rheumatol. Int.
Genetic aspects of ankylosing spondylitis
Best Pract. Res. Clin. Rheumatol.
Pathogenesis of ankylosing spondylitis and reactive arthritis
Curr. Opin. Rheumatol.
Pathogenesis of ankylosing spondylitis — mechanisms of disease manifestation and chronicity
Z. Rheumatol.
Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis
Rheumatol. Int.
Ankylosing spondylitis: an autoimmune disease?
Ann. Rheum. Dis.
Recent studies on the genetic basis of ankylosing spondylitis
Curr. Rheumatol. Rep.
HLA B27 and the genetics of ankylosing spondylitis
Ann. Rheum. Dis.
Free radicals in the physiological control of cell function
Physiol. Rev.
Cited by (23)
Evaluation of thiol-disulfide homeostasis in active ankylosing spondylitis patients
2022, Reumatologia ClinicaCitation Excerpt :Similarly we found an increase for disulfide in highly and very highly AS group in our study. Although in various studies, it has been shown that oxidative stress related parameters decreased in patients with AS compared to the healthy control group.17 However, there are studies with contradictory results.18
Oxidative stress and immunological biomarkers in Ankylosing spondylitis patients
2020, Gene ReportsCitation Excerpt :ROS is released into the extracellular space and damages the nearby tissues in inflammation and phagocytosis reactions, increasing the level of acute-phase proteins (Guillot et al., 2014). On the other hand, it has been also reported that the oxidative stress have a significant role in AS pathogenesis (Stanek et al., 2010a; Feijóo et al., 2009). AS is a chronic inflammatory rheumatic disorder mainly described by changes in the sacroiliac joint and the axial skeleton.
Levels of lipid peroxidation and antioxidant vitamins in plasma and erythrocytes of patients with ankylosing spondylitis
2011, Clinical BiochemistryCitation Excerpt :Hence, we observed the presence of oxidative stress in the patients. A limited number of in vivo or in vitro studies of the blood of patients with AS regarding the status of antioxidant redox systems and LP concentrations on the pathogenesis of AS have been reported [8, 9, 19–21]. To the best of our knowledge however, the current study is the first to compare the role of all antioxidant vitamins with particular reference to oxidative stress and antioxidant redox systems in the plasma of patients with AS.
Effect of a mitochondria-targeted vitamin e derivative on mitochondrial alteration and systemic oxidative stress in mice
2011, British Journal of NutritionFOXO3a Alleviates the Inflammation and Oxidative Stress via Regulating TGF-β and HO-1 in Ankylosing Spondylitis
2022, Frontiers in Immunology